Argutus Medical prides itself on the research and development of some of the world's most interesting early biomarkers for the kidney, liver and pancreas for use in clinical and preclinical settings. The simplicity of these markers is their strength. Described as leaky, these biomarkers will present in urine if their host or origin cell has been damaged.
Pancreatic Injury Testing Service | Cat. No. | Product Description | Assay Format |
| TEST BBU | Argutus Medical Trypsinogen Activation Peptide (TAP) | 96 Well EIA |
Click Here for to access the exciting list of antibodies available from Argutus Medical